Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cardiovascular Research

• Publication date

  2016-02-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1093/cvr/cvv237PMID 26472131PMCID PMC4724935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo

  2015cited by this paper
• Macrophage subsets in atherosclerosis

  2015cited by this paper
• Amphiphilic Nanoparticles Repress Macrophage Atherogenesis: Novel Core/Shell Designs for Scavenger Receptor Targeting and Down-Regulation

  2014cited by this paper
• In silico design of anti-atherogenic biomaterials.

  2013cited by this paper
• Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors.

  2013cited by this paper
• Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

  2012cited by this paper
• Convergence of Nanotechnology and Cardiovascular Medicine

  2012cited by this paper
• Kinetically Assembled Nanoparticles of Bioactive Macromolecules Exhibit Enhanced Stability and Cell‐Targeted Biological Efficacy

  2012cited by this paper
• Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis.

  2011cited by this paper
• Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2.

  2011cited by this paper
• Macrophage polarization in metabolic disorders: functions and regulation

  2011cited by this paper
• Nanoparticles and Inflammation

  2011cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Macrophage Plasticity in Experimental Atherosclerosis

  2010cited by this paper
• Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

  2010cited by this paper
• Vitamin E and Cardiovascular Disease

  2010cited by this paper
• The monocyte/macrophage as a therapeutic target in atherosclerosis.

  2009cited by this paper
• Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters.

  2009cited by this paper
• Targeting atherosclerosis by using modular, multifunctional micelles

  2009cited by this paper
• Macrophage diversity and polarization in atherosclerosis: a question of balance.

  2009cited by this paper
• Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

  2009cited by this paper
• Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects.

  2008cited by this paper
• Heterogeneity of human macrophages in culture and in atherosclerotic plaques.

  2008cited by this paper
• Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis

  2008cited by this paper
• The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line.

  2008cited by this paper
• Composite block copolymer stabilized nanoparticles: simultaneous encapsulation of organic actives and inorganic nanostructures.

  2008cited by this paper
• Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation

  2008cited by this paper
• New vistas on macrophage differentiation and activation

  2007cited by this paper
• Comprar Nanotoxicology: Characterization, Dosing and Health Effects | Nancy A. Monteiro-Riviere | 9781420045147 | Informa Healthcare

  2007cited by this paper
• Nanotoxicology : characterization, dosing and health effects

  2007cited by this paper
• Renal clearance of quantum dots

  2007cited by this paper
• Cytokines in atherosclerosis: pathogenic and regulatory pathways.

  2006cited by this paper
• Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.

  2006cited by this paper
• Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.

  2005cited by this paper
• Amphiphilic Scorpion-like Macromolecules: Design, Synthesis, and Characterization

  2004cited by this paper
• Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro

  2004cited by this paper
• Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway

  2004cited by this paper
• Antioxidants and atherosclerosis.

  2004cited by this paper
• Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits.

  2004cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• Antioxidants, statins, and atherosclerosis.

  2003cited by this paper
• Flash NanoPrecipitation of Organic Actives and Block Copolymers using a Confined Impinging Jets Mixer

  2003cited by this paper
• Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite.

  2002cited by this paper
• Macrophage-specific expression of class A scavenger receptors in LDL receptor−/− mice decreases atherosclerosis and changes spleen morphology DOI 10.1194/jlr.M200116-JLR200

  2002cited by this paper
• Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis?

  2002cited by this paper
• Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling Pathways

  2002cited by this paper
• Scavenger Receptors, Oxidized LDL, and Atherosclerosis

  2001cited by this paper
• Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.

  2001cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.

  1998cited by this paper
• Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis.

  1997cited by this paper
• The role of oxidized lipoproteins in atherogenesis.

  1996cited by this paper
• Role of vitamin E in preventing the oxidation of low-density lipoprotein.

  1991cited by this paper
• Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein.

  1984cited by this paper

• Differential Regulatory Effects of Cannabinoids and Vitamin E Analogs on Cellular Lipid Homeostasis and Inflammation in Human Macrophages

  2026influential citation
• 20 years of flash nanoprecipitation - from controlled precipitation to global medicine.

  2025cites this paper
• Polydopamine and hyaluronic acid-coated dual-responsive silica nanoparticles for targeted atherosclerosis imaging and therapy

  2025cites this paper
• Efferocytosis: a therapeutic strategy for diabetes and its vascular complications

  2025cites this paper
• Macrophage-Targeted Nanomedicine for the Treatment of Atherosclerosis

  2025cites this paper
• Nano Delivery System for Atherosclerosis

  2024cites this paper
• Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease

  2024cites this paper
• Formulation and evaluation of nanobiotherapeutics of Terminalia arjuna through plant tissue culture for atherosclerosis

  2024cites this paper
• Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics

  2024cites this paper
• Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications

  2022cites this paper
• Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.

  2021cites this paper
• Effect of acute ammonia toxicity on inflammation, oxidative stress and apoptosis in head kidney macrophage of Pelteobagrus fulvidraco and the alleviation of curcumin.

  2021cites this paper
• Collagenase‐Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis

  2020cites this paper
• Molecular imaging of advanced atherosclerotic plaques with folate receptor-targeted 2D nanoprobes

  2019cites this paper
• Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management

  2019cites this paper
• Vitamin E: Regulatory role in the cardiovascular system

  2019cites this paper
• Translational Exploration and Clinical Testing of Silica–Gold Nanoparticles in Development of Multifunctional Nanoplatform for Theranostics of Atherosclerosis

  2018cites this paper
• Water-Soluble Vitamin E-Tocopheryl Phosphate.

  2018cites this paper
• It's the Metabolism That Makes Macrophages Detectable in the Magnetic Resonance Scanner: Immune Cell Detection by Hyperpolarized 13C Magnetic Resonance Imaging.

  2018cites this paper
• Hypertension: Focus on autoimmunity and oxidative stress.

  2018cites this paper
• New heights and hot topics in Cardiovascular Research

  2018cites this paper
• Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis

  2018cites this paper
• Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms

  2017cites this paper
• Biomedical Applications of Nanotechnology and Nanomaterials

  2017cites this paper
• Translational research into vascular wall function: regulatory effects of systemic and specific factors

  2017cites this paper
• Oxidative Stress, Inflammation, and Vascular Aging in Hypertension

  2017cites this paper
• Nanomedicines for dysfunctional macrophage-associated diseases.

  2017cites this paper
• [Molecular Aspects of Translational Cardiology in Vascular Wall Research].

  2017cites this paper
• Editorial highlights from Cardiovascular Research

  2017cites this paper
• The role of infiltrating immune cells in dysfunctional adipose tissue

  2017cites this paper
• Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.

  2017cites this paper
• Combination nanotherapy penetrates atherosclerosis.

  2016cites this paper